Last updated on May 2017

Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy


Brief description of study

This is an observational, retrospective, non-interventional study that will include schizophrenic patients who were initiated with aripiprazole once-monthly as per normal clinical practice at least 6 months before the data collection starts (inclusion visit), and is designed to evaluate demographic and clinical predictors of persistence with this treatment. Data from each patient will be collected after informed consent is signed (inclusion visit), and will include retrospective information from the start of aripiprazole once-monthly treatment initiation (index date) until the follow-up/inclusion visit (minimum of 6 months after the index date). Data will be retrospectively collected from all visits occurring as per clinical practice (usually once monthly).

Clinical Study Identifier: NCT03005769

Contact Investigators or Research Sites near you

Start Over

Joaquin Sanchez-Covisa

Ospedale Maria S.S. dello splendore
Giulianova, Italy
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.